Invention Grant
- Patent Title: Methods of assessing antibody-drug conjugates
-
Application No.: US16121909Application Date: 2018-09-05
-
Publication No.: US10976241B2Publication Date: 2021-04-13
- Inventor: Andria Skinner , Natallia Kulyba
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Cooley LLP
- Agent Matthew Pavao; Ivor R. Elrifi
- Main IPC: G01N21/31
- IPC: G01N21/31 ; G01N33/68 ; G01N30/02 ; A61K47/68 ; G16B5/00 ; G16C20/30 ; G01J3/427 ; G01N21/27 ; G01N30/88 ; G01N21/33 ; B01D15/34
Abstract:
The present disclosure provides methods of assessing DAR of ADC products that provide advantages over known methods. Specifically, methods of the disclosure can be used in high-throughput applications and/or without having to dilute ADC samples during the assessment.
Public/Granted literature
- US20190079005A1 METHODS OF ASSESSING ANTIBODY-DRUG CONJUGATES Public/Granted day:2019-03-14
Information query
IPC分类:
